Erwin W - Search Results

1

Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications.

Murthy R, Nunez R, Szklaruk J, Erwin W, Madoff DC, Gupta S, Ahrar K, Wallace MJ, Cohen A, Coldwell DM, Kennedy AS, Hicks ME. Murthy R, et al. Among authors: erwin w. Radiographics. 2005 Oct;25 Suppl 1:S41-55. doi: 10.1148/rg.25si055515. Radiographics. 2005. PMID: 16227496 Review.

2

Establishment of the radiation effect of yttrium-90 microspheres: role of C-arm CT.

Murthy R, Mutha P, Madoff DC, Mahvash A, Erwin W. Murthy R, et al. Among authors: erwin w. J Vasc Interv Radiol. 2009 Mar;20(3):422-4. doi: 10.1016/j.jvir.2008.11.024. Epub 2009 Jan 23. J Vasc Interv Radiol. 2009. PMID: 19167244 No abstract available.

3

Lung perfusion imaging can risk stratify lung cancer patients for the development of pulmonary complications after chemoradiation.

Gayed IW, Chang J, Kim EE, Nuñez R, Chasen B, Liu HH, Kobayashi K, Zhang Y, Liao Z, Gohar S, Jeter M, Henderson L, Erwin W, Komaki R. Gayed IW, et al. Among authors: erwin w. J Thorac Oncol. 2008 Aug;3(8):858-64. doi: 10.1097/JTO.0b013e31818020d5. J Thorac Oncol. 2008. PMID: 18670303 Free PMC article.

4

Acquisition parameters for oncologic imaging with a new SPECT/multislice CT scanner.

Núñez R, Erwin WD, Wendt RE 3rd, Stachowiak A, Mar M, Stevens D, Madewell JE, Yeung HW, Macapinlac HA. Núñez R, et al. Among authors: erwin wd. Mol Imaging Biol. 2010 Apr;12(2):110-38. doi: 10.1007/s11307-009-0266-4. Epub 2010 Jan 5. Mol Imaging Biol. 2010. PMID: 20049543 Review.

5

90Sr content in 90Y-labeled SIR-spheres and Zevalin.

Metyko J, Erwin W, Poston J Jr, Jimenez S. Metyko J, et al. Among authors: erwin w. Health Phys. 2014 Nov;107(5 Suppl 3):S177-80. doi: 10.1097/HP.0000000000000171. Health Phys. 2014. PMID: 25272027

6

Phase I Study of P-cadherin-targeted Radioimmunotherapy with ⁹⁰Y-FF-21101 Monoclonal Antibody in Solid Tumors.

Subbiah V, Erwin W, Mawlawi O, McCoy A, Wages D, Wheeler C, Gonzalez-Lepera C, Liu H, Macapinlac H, Meric-Bernstam F, Hong DS, Pant S, Le D, Santos E, Gonzalez J, Roszik J, Suzuki T, Subach RA, Madden T, Johansen M, Nomura F, Satoh H, Matsuura T, Kajita M, Nakamura E, Funase Y, Matsushima S, Ravizzini G. Subbiah V, et al. Among authors: erwin w. Clin Cancer Res. 2020 Nov 15;26(22):5830-5842. doi: 10.1158/1078-0432.CCR-20-0037. Epub 2020 Aug 18. Clin Cancer Res. 2020. PMID: 32816889 Clinical Trial.

7

Estimation of yttrium-90 Zevalin tumor-absorbed dose in ocular adnexal lymphoma using quantitative indium-111 Zevalin radionuclide imaging.

Erwin WD, Esmaeli B. Erwin WD, et al. Nucl Med Commun. 2009 Sep;30(9):681-6. doi: 10.1097/MNM.0b013e32832a6e4d. Nucl Med Commun. 2009. PMID: 19528874 Clinical Trial.

8

Long-lived impurities of 90Y-labeled microspheres, TheraSphere and SIR-spheres, and the impact on patient dose and waste management.

Metyko J, Williford JM, Erwin W, Poston J Jr, Jimenez S. Metyko J, et al. Among authors: erwin w. Health Phys. 2012 Nov;103(5 Suppl 3):S204-8. doi: 10.1097/HP.0b013e31826566f0. Health Phys. 2012. PMID: 23026974

9

Effect of voxel size and computation method on Tc-99m MAA SPECT/CT-based dose estimation for Y-90 microsphere therapy.

Pasciak AS, Erwin WD. Pasciak AS, et al. IEEE Trans Med Imaging. 2009 Nov;28(11):1754-8. doi: 10.1109/TMI.2009.2022753. IEEE Trans Med Imaging. 2009. PMID: 19884064

10

Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra Therapy.

Etchebehere EC, Araujo JC, Milton DR, Erwin WD, Wendt RE 3rd, Swanston NM, Fox P, Macapinlac HA, Rohren EM. Etchebehere EC, et al. Clin Nucl Med. 2016 Apr;41(4):268-73. doi: 10.1097/RLU.0000000000001118. Clin Nucl Med. 2016. PMID: 26828141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page